About Anuncia Medical

The name Anuncia comes from Panthera Uncia, the species name of the snow leopard. These animals live in mountainous regions of Asia and have been called by the World Wildlife Foundation “Guardians of the Headwaters” as they roam the headwater areas of the western basins.

The origin of the word hydrocephalus comes from the Greek  hydrokephalon, from hydro ‘water’+ kephalē ‘head’. The snow leopard, or Guardian of the Headwaters, is a symbol of Anuncia’s dedication to inform the hydrocephalus community about new technologies and solutions aimed toward improving patient’s lives. We are also dedicated to providing clinicians innovative technologies to treat hydrocephalus and other CSF management disorders.

The Anuncia Medical Executive Team

The Anuncia team consists of scientists, clinicians, engineers, patients, and professionals with a depth of expertise in hydrocephalus and medical technology innovation. Our focus is to develop an innovative therapeutic platform of products to address unmet clinical needs in the management of CSF disorders.

Elsa Chi Abruzzo

RAC, FRAPS - President & CEO

Matt Casiraro

VP of R&D

Natalie Eagleburger

VP, Regulatory, Clinical, and Quality

Mark Geiger

VP, Sales and Marketing

Natalie Stevens

Chief Financial Officer

David Szabo

VP of Manufacturing

Advisors

Ramin Eskandari, MD
Consulting Chief Medical Officer

Michael Muhonen, MD
Consulting Chief Scientific Officer

Scientific Advisory Board

Anthony Avellino, MD, MBA
Mark Luciano, MD
Joe Madsen, MD
Bryn Martin, PhD
Carrie Muh, MD
Sudhakar Vadivelu, DO

Board of Directors

Elsa Chi Abruzzo
PJ Anand
David Donabedian
Edgar D. Jannotta, Jr.
Stephen Oesterle, MD
Stanton Rowe
Richard Upton (Chairperson)